WUXI BIOLOGICS CAYMAN INC USD00000083 144A REG S - G97008117
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GILDER GAGNON HOWE & CO LLC | History | Reduced | 8,292,994 | 98,446 | 0.56% | 0.77% | 1 | -789,126 | -8.69% | Q4 2021 | Feb 14, 2022 |
| LAIRD NORTON TRUST COMPANY, LLC | History | New | 10,500 | 124 | 0.01% | — | 2 | +10,500 | New | Q4 2021 | Feb 07, 2022 |